Cargando…
Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology
BACKGROUND: Binge-eating disorder (BED) is a common psychiatric condition with adverse psychological and metabolic consequences. Lisdexamfetamine (LDX) is the only approved BED drug treatment. New drugs to treat BED are urgently needed. METHODS: A comprehensive review of published psychopathological...
Autores principales: | Heal, David J, Smith, Sharon L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150143/ https://www.ncbi.nlm.nih.gov/pubmed/34318734 http://dx.doi.org/10.1177/02698811211032475 |
Ejemplares similares
-
Sleep Quality and Eating Disorder-Related Psychopathologies in Patients with Night Eating Syndrome and Binge Eating Disorders
por: Tzischinsky, Orna, et al.
Publicado: (2021) -
Can early change in eating disorder psychopathology predict outcome in guided self-help for binge eating?
por: Jenkins, Paul E., et al.
Publicado: (2020) -
Executive Functions of Adults with Binge-Eating Disorder: The Role of Weight Status and Psychopathology
por: Busch, Nele, et al.
Publicado: (2021) -
Two of a Kind? Mapping the Psychopathological Space between Obesity with and without Binge Eating Disorder
por: Sommer, Laura Marie, et al.
Publicado: (2021) -
The connection between childhood maltreatment and eating disorder psychopathology: a network analysis study in people with bulimia nervosa and with binge eating disorder
por: Monteleone, Alessio Maria, et al.
Publicado: (2021)